These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 1763253)

  • 1. [Genetics of neurofibromatosis: recent progress and prospects].
    Maillet-Vioud M; Narod S; Assouline D; Sobol H; Fischer G; Robert JM; Lenoir GM
    Rev Neurol (Paris); 1991; 147(10):644-52. PubMed ID: 1763253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurofibromatosis type 2 and von Hippel-Lindau disease: from gene cloning to function.
    Kley N; Whaley J; Seizinger BR
    Glia; 1995 Nov; 15(3):297-307. PubMed ID: 8586465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [von Recklinghausen's disease and its pathogenesis].
    Sakai A; Suzuki K
    Nihon Rinsho; 1995 Nov; 53(11):2688-90. PubMed ID: 8538027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic linkage of bilateral acoustic neurofibromatosis to a DNA marker on chromosome 22.
    Rouleau GA; Wertelecki W; Haines JL; Hobbs WJ; Trofatter JA; Seizinger BR; Martuza RL; Superneau DW; Conneally PM; Gusella JF
    Nature; 1987 Sep 17-23; 329(6136):246-8. PubMed ID: 2888021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurofibromatosis: from gene to phenotype.
    Ponder BA
    Semin Cancer Biol; 1992 Jun; 3(3):115-20. PubMed ID: 1511154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Molecular-genetic aspects of neurofibromatosis].
    Hulsebos TJ
    Ned Tijdschr Geneeskd; 1997 Mar; 141(13):620-3. PubMed ID: 9190537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Basic science and clinical aspects of familial brain tumors].
    Kanno H
    Brain Nerve; 2012 May; 64(5):557-64. PubMed ID: 22570069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neurofibromatosis].
    Wolkenstein P; Decq P
    Neurochirurgie; 1998 Nov; 44(4):267-72. PubMed ID: 9864698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD44 expression is aberrant in benign Schwann cell tumors possessing mutations in the neurofibromatosis type 2, but not type 1, gene.
    Sherman L; Jacoby LB; Lampe J; Pelton P; Aguzzi A; Herrlich P; Ponta H
    Cancer Res; 1997 Nov; 57(21):4889-97. PubMed ID: 9354454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurofibromatosis and central nervous system tumors in childhood.
    Mapstone TB
    Neurosurg Clin N Am; 1992 Oct; 3(4):771-9. PubMed ID: 1392574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurocutaneous syndromes: neurofibromatosis 1, neurofibromatosis 2, and tuberous sclerosis.
    Korf BR
    Curr Opin Neurol; 1997 Apr; 10(2):131-6. PubMed ID: 9146993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumour suppressor genes, immunology and local manifestations of neurofibromatosis phenotypes.
    Gerosa PL; Spinelli M; Iannarelli S; Giussani G; Canepari C; Fontana A; Vai C; Bizzozero L
    Panminerva Med; 1996 Sep; 38(3):157-63. PubMed ID: 9009679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neurofibromatosis type 2 (central neurofibromatosis or bilateral acoustic neuromas, vestibular schwannomas): from phenotype to gene].
    Sabol Z; Kipke-Sabol L; Miklić P; Hajnsek-Propadalo S; Sabol F
    Lijec Vjesn; 2006; 128(9-10):309-16. PubMed ID: 17128670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Neurofibromatosis type 1 (von Recklinghausen's disease or peripheral neurofibromatosis): from phenotype to gene].
    Sabol Z; Kipke-Sabol L
    Lijec Vjesn; 2005; 127(11-12):303-11. PubMed ID: 16583938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurofibromatosis. Nosological considerations.
    Badiu C; Stefanache F
    Rev Med Chir Soc Med Nat Iasi; 2000; 104(2):39-44. PubMed ID: 12089989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular targets for emerging anti-tumor therapies for neurofibromatosis type 1.
    Dilworth JT; Kraniak JM; Wojtkowiak JW; Gibbs RA; Borch RF; Tainsky MA; Reiners JJ; Mattingly RR
    Biochem Pharmacol; 2006 Nov; 72(11):1485-92. PubMed ID: 16797490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Von Recklinghausen's disease: experimental models and comparative aspects].
    Turusov VS; Kardeza A; Ribal'ta T
    Arkh Patol; 1996; 58(5):3-13. PubMed ID: 9005821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention and control of neurofibromatosis: memorandum from a joint WHO/NNFF meeting.
    Bull World Health Organ; 1992; 70(2):173-82. PubMed ID: 1600579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnostics of neurofibromatosis (Recklinghausen disease)].
    Ardashev VN; Seriakov AP; Nikolaeva SN; Konev AV; Smolin AV
    Voen Med Zh; 2004 Jun; 325(6):41-4. PubMed ID: 15327140
    [No Abstract]   [Full Text] [Related]  

  • 20. Mosaicism in sporadic neurofibromatosis type 1: variations on a theme common to other hereditary cancer syndromes?
    Kehrer-Sawatzki H; Cooper DN
    J Med Genet; 2008 Oct; 45(10):622-31. PubMed ID: 18511569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.